Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1996-07-09
1998-07-14
Jordan, Kimberly
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514251, A61K 3170, A61K 31525
Patent
active
057804460
ABSTRACT:
The present invention relates to methods of treating, as well as preventing extravasation injury. In particular, the present invention pertains to photochemotherapeutic methods of prophylaxis and/or treatment of extravasation injury induced by vesicant antineoplastic drugs and other pharmaceutical formulations. In accordance with the present invention, extravasation injury is prevented or minimized by the coadministration of photoinactivation inducing compounds in a formulation comprising a vesicant antineoplastic or other pharmaceutical formulation, and subsequently exposing the injection or infusion site to photoexciting light.
REFERENCES:
patent: 4124598 (1978-11-01), Hearst et al.
patent: 4169204 (1979-09-01), Hearst et al.
patent: 4196281 (1980-04-01), Hearst et al.
patent: 4312883 (1982-01-01), Baccichetti et al.
patent: 4398031 (1983-08-01), Bender et al.
patent: 4827016 (1989-05-01), Morgan
patent: 4906100 (1990-03-01), Rice et al.
patent: 5047245 (1991-09-01), Bally et al.
patent: 5049392 (1991-09-01), Weiner et al.
patent: 5106951 (1992-04-01), Morgan, Jr. et al.
patent: 5171578 (1992-12-01), Bally et al.
patent: 5212291 (1993-05-01), Murduck et al.
patent: 5216176 (1993-06-01), Heindel et al.
patent: 5308874 (1994-05-01), Sanchez et al.
patent: 5356929 (1994-10-01), Heindel et al.
patent: 5461080 (1995-10-01), Sanchez et al.
patent: 5468499 (1995-11-01), Chan et al.
patent: 5475092 (1995-12-01), Chari et al.
Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th ed. (Ed. J.G. Hardman, et al.) (1996) "Chemotherapy of Neoplastic Diseases," MacGraw Hill, New York, pp. 1225-1237, 1242-1243, 1257-1260, 1263-1266.
Rudolph et al. (1976) "Skin Ulcers Due to Adriamycin," Cancer 38:1087-1094.
Devita et al., Cancer: Principles and Practice of Oncology, 3rd edition, Philadelphia, Lippincott, 1989:2386.
Dorr (1990) "Antidotes to Vesicant Chemotherapy Extravasations," Blood Rev. 4:41-60.
Andersson and Dahlstr.o slashed.m (1993) "Clinical Results After Doxorubicin Extravasation Treated With Excision Guided by Fluorescence Microscopy," Eur J. Cancer 29A:1712-1714.
Lichtenstien and Goldman (1970) "Riboflavin-Methotrexate Interactions: Photochemical Reaction and Competition for Transport in the L1210 Mouse Leukemia Cell," Biochem. Pharmacol. 19:1229-1239.
Granzow et al. (1995) "Riboflavin-mediated Photosensitization of Vinca Alkaloids Distorts Drug Sensitivity Assays," Cancer Res. 55:4837-4843.
Yajima and Mizunoya (1981) "Kinetics of Photoinactivation and Photooxidation of Mitomycin C in the Presence of Riboflavin," J. Biochem. 89:929-936.
Sanfilippo et al. (1968) "Photodynamic Action of Daunomycin I -Effect on Bacteriophage T2 and Bacteria," Giorn. Microbiol. 16:50.
Verini et al. (1968) "Photodynamic Action of Daunomycin II -Effect on Animal Viruses," Giorn. Microbiol. 16:55.
Di Marco et al. (1972) "Interaction of Daunomycin with Nucleic Acids: Effect of Photoirradidiation of the Complex," Experientia 28:327-329.
Daugherty et al. (1979) "Direct In Vitro Photoaffinity Labeling of DNA with Daunorobicin, Adriamycin, and Rubidazone," Biochem. Biophys. Acta 565:13-21.
Williams and Tritton (1981) "Photoinactivation of Anthracyclines," Photochem. Photobiol. 34:131-134.
Gray and Phillips (1981) "Ultraviolet Photoirradiation of Daunomycin And DNA-Daunomycin Complexes," Photochem. Photobiol. 33:297-303.
Gray et al. (1982) "Photosensitized Degradation of DNA by Daunomycin," Photochem. Photobiol. 36:49-57.
Yee et al. (1984) "Photoaffinity Labeling of the Sarcoma 180 Cell Surface by Daunomycin," Cancer Res. 44:1898-1903.
Luedke et al. (1979) "Histopathogenesis of Skin and Subcutaneous Injury Induced by Adriamycin," Plast. Reconstr. Surg. 63:463-465.
Hearst (1989) "Photochemistry of the Psoralens," Chemical Research in Toxicology, 2:69-75.
Anderson and Vorhees (1980) "Psoralen Photochemotherapy of Cutaneous Disorders," Ann. Rev. Pharmacol. Toxicol., 20:235-257.
Kharasch and Novak (1981) "The Molecular Basis for Complexation of Adriamycin with Flavin Mononucleotide and Flavin Adenine Dinucleotide," Arch. Biochem. Biophys. 212:20-36.
Byrom and Turnbull (1967) "Excited States of Flavine Coenzymes-II. Anaerobic Oxidation of Amino Acids by Excited Riboflavine Derivatives," Photochem. Photobiol. 6:125-131.
Friedrich (1988) in Vitamins, Friedrich, ed., W. de Gruyter, Berlin, pp. 403-471.
Kim et al. (1993) "Photosensitized Formation of Ascorbate Radicals by Riboflavin: An ESR Study," Photochem. Photobiol. 57:777-784.
Chinami et al. (1984) "Semiquinone Formation of Adriamycin by Oxidation at para-OH Residue," Biochem. Int. 8:299-304.
Silva and Godoy (1994) "Riboflavin Sensitized Photooxidation of Tyrosine," Int. J. Vit. Nutr. Res. 64:253-256.
Brawley et al. (1993) "Hydrogen peroxide generation in a model paediatric parenteral amino acid solution," Clin. Sci. 85:709-712.
Rosenfeld et al. (1984) "Fetal and Neonatal Medicine: Prevention of bronchopulmonary dysplasia by administration of bovine superoxide dismutase in preterm infants with respiratory distress syndrome," J. Pediatr. 105:781-785.
Ramu et al. (1984) "Reversal of Acquired Resistance to Doxorubicin in P388 Murine Leukemia Cells by Perhexiline Maleate," Cancer Res. 44:144-148.
Girotti (1983) "Yearly Review: Mechanisms of Photosensitization," Photochem. Photobiol. 38:745-751.
Dorr et al. (1980) "Experimental Model of Doxorubicin Extravasation in the Mouse," J. Pharmacol. Methods 4:237-250.
Dorr et al. (1980) "The Limited Role of Corticosteroids in Ameliorating Experimental Doxorubicin Skin Toxicity in the Mouse," Cancer Chemother. Pharmacol. 5:17-20.
Averbuch et al. (1986) "Doxorubicin-Induced Skin Necrosis in the Swine Model: Protection With a Novel Radical Dimer," J. Clin. Oncol. 4:88-94.
Dahlstr.o slashed.m et al., "Fluorescence Microscopic Demonstration and Demarcation of Doxorubricin Extravasation," Cancer 65:1722-1726 (1990).
Iyengar, "Neural Differentiation As An Expression Of UV Sensitivity," Acta. Anatomica 143:236-240 (1981).
Synderman and Krasna, "Adriamycin Extravasation Injuries," Plastic & Reconstructive Surg. 77:683-684 (1986).
Braun-Falco et al., Dermatology (Springer-Verlag) New York, pp. 1189-1191 (1984).
Dall'Aqua et al., "New Monofunctional Reagents for DNA as Possible Agents for the photochemotherapy of Psoriasis: Derivatives of 4,5'-Dimethylangelicin," J. Med. Chem. 24:178-184 (1981).
Hida et al., "Effects Of Antioxidants On Adriamycin-Induced Microsomal Lipid Peroxidation," Biol. Trace Element Res. 47:111-116 (1995).
Larson, "Alterations in Wound Healing Secondary to Infusion Injury," Clinics in Plastic Surgery 17(3):509-517 (1990).
Lawrence et al., "Topical dimethylsulfoxide may prevent tissue damage from anthracycline extravasation," Cancer Chemother Pharmacol 23:316-318 (1989).
Lee et al., Adriamycin Induced Myocardial Dysfunction In Vitro Is Mediated By Free Radicals, Am. J. Physiol. 261:H989-H9895 (1991).
Loth and Eversmann, "Treatment Methods For Extravasations Of Chemotherapeutic Agents: A Comparative Study," J. Hand Surg. 11:388-396 (1986).
Ludwig et al., "Prevention of Cytotoxic Drug Induced Skin Ulcers With DMSO and Alpha-Tocopherol," Eur. J. Ca & Clin. Oncol. 23:327-329 (1987).
Okano et al., "Doxorubicin-Induced Skin Ulcer in the Piglet," Cancer Treatment Reports 67(12):1075-1078 (1983).
Rudolph and Larson, "Etiology and Treatment of Chemotherapeutic Agent Extravasation Injuries: A Review," Journal of Clinical Oncology, 5(7):1116-1126 (1987).
Soble et al., "Dose-dependent skin ulcers in mice treated with DNA binding antitumor antibiotics," Cancer Chemother Pharmacol 20:33-36 (1987).
Speranza et al., "Cells Enriched for Catalase Are Sensitized to the Toxicities of Bleomycin, Adriamycin, and Paraquat," J. Biol. Chem. 268:19039-19043 (1993).
Taylor et al., "Glutathione Peroxidase Protects Cultured Mammalian Cells From the Toxicity of Adriamycin and Paraquat," Arch. Biochem. & Biophysics 305:600-605 (1993).
Tsavaris et al., "Conservative Approach to the Treatment of Chemotherapy Induced Extravasation," J. Derm. Surg. & Oncol. 16:519-522 (1990).
Wang et al., "Effect of Vitamin E Against Adriamycin-Induced Tox
Baylor College of Medicine
Jordan Kimberly
LandOfFree
Formulations of vesicant drugs and methods of use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Formulations of vesicant drugs and methods of use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Formulations of vesicant drugs and methods of use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1881830